Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme.
Smith C, Lineburg KE, Martins JP, Ambalathingal GR, Neller MA, Morrison B, Matthews KK, Rehan S, Crooks P, Panikkar A, Beagley L, Le Texier L, Srihari S, Walker D, Khanna R.
Smith C, et al. Among authors: beagley l.
J Clin Invest. 2020 Nov 2;130(11):6041-6053. doi: 10.1172/JCI138649.
J Clin Invest. 2020.
PMID: 32750039
Free PMC article.
Clinical Trial.